RNF41 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.989400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.586600E-01
Normal-vs-Stage2
5.337800E-01
Normal-vs-Stage3
5.445500E-02
Normal-vs-Stage4
8.511400E-01
Stage1-vs-Stage2
2.038400E-01
Stage1-vs-Stage3
1.096400E-02
Stage1-vs-Stage4
9.165200E-01
Stage2-vs-Stage3
1.150630E-01
Stage2-vs-Stage4
3.459200E-01
Stage3-vs-Stage4
2.618200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.378000E-01
Normal-vs-AfricanAmerican
9.217200E-01
Normal-vs-Asian
1.949600E-01
Caucasian-vs-AfricanAmerican
7.780800E-01
Caucasian-vs-Asian
1.014590E-01
AfricanAmerican-vs-Asian
2.140000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.725800E-01
Normal-vs-Female
6.056200E-01
Male-vs-Female
5.435600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.678000E-01
Normal-vs-Age(41-60Yrs)
8.001600E-01
Normal-vs-Age(61-80Yrs)
4.826400E-01
Normal-vs-Age(81-100Yrs)
2.756400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.329600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.343800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.212950E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.244200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.468100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.611000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.131200E-01
Normal-vs-Daily Drinker
3.518400E-01
Normal-vs-Weekly Drinker
2.038200E-01
Normal-vs-Occasional Drinker
7.325800E-01
Normal-vs-Social Drinker
9.412400E-01
Non Drinker-vs-Daily Drinker
3.212000E-01
Non Drinker-vs-Weekly Drinker
9.849400E-01
Non Drinker-vs-Occasional Drinker
5.638400E-03
Non Drinker-vs-Social Drinker
9.731600E-02
Daily Drinker-vs-Weekly Drinker
4.469600E-01
Daily Drinker-vs-Occasional Drinker
2.885700E-02
Daily Drinker-vs-Social Drinker
2.400200E-01
Weekly Drinker-vs-Occasional Drinker
1.741540E-02
Weekly Drinker-vs-Social Drinker
1.331640E-01
Occasional Drinker-vs-Social Drinker
4.846800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.535220E-01
Normal-vs-Grade 2
1.985560E-02
Normal-vs-Grade 3
1.237800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.798800E-01
Grade 1-vs-Grade 3
3.748600E-01
Grade 1-vs-Grade 4
1.535220E-01
Grade 2-vs-Grade 3
6.809200E-01
Grade 2-vs-Grade 4
1.985560E-02
Grade 3-vs-Grade 4
1.237800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.831000E-01
Normal-vs-NonDiabetic
6.317600E-01
Diabetic-vs-NonDiabetic
8.928400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.238000E-01
Normal-vs-NoPancreatitis
6.415400E-01
Pancreatitis-vs-NoPancreatitis
8.742400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.641000E-01
Normal-vs-N1
5.878600E-01
N0-vs-N1
7.288600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.148200E-01
Normal-vs-TP53-NonMutant
9.567800E-01
TP53-Mutant-vs-TP53-NonMutant
3.989000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
